Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

Executive Summary

European Commission’s Scientific Committee on Consumer Safety releases guidance to help firms comply with nanotech reporting and labelling requirements that go into effect next year under the recast European Cosmetics Directive. More news in brief.

Advertisement

Related Content

EC's Delayed Nano Inventory Reflects Notification Errors, Definitional Challenges
Revlon Returns To Salon Channel With $660 Mil. Colomer Acquisition
Almay Looks For Boost, Reentering Lip Color In Q2 With Liquid Lip Balm
Cosmetics Europe Preps Industry For Increased Market-Surveillance Duties
European Commission Seeks Cosmetic Nanotech Experts For Committee Work
Revlon’s Flagship Helps Achieve Q2 Sales Gain; Almay Makeover Ongoing
Safety Testing For Nano-Cosmetics Must Address Actual Use Scenarios
CIR Panel Grapples With Safety Review Protocol For Nanomaterials
In Brief
Parliament Passes Updated Cosmetics Directive For All 27 European States

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS018179

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel